Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Innovations in Pharmacy|May 19, 2021
Establishing Credibility for Medical Marijuana: The Proposed Prometheus Dispensary Registry for Botanical CannabisPaul C LangleyInnovations in Pharmacy|May 19, 2021
Meeting Physician Compliance Recommendations in the Management of Opioids in Chronic Pain: The Chronic Pain Management Registry (CPMR)Paul C LangleyInnovations in Pharmacy|May 19, 2021
Establishing Practice Risk Management and Outcomes Claims for Medical Marijuana Dispensaries: Questions Legislators Should AskPaul C LangleyInnovations in Pharmacy|May 21, 2021
Nonsense on Stilts - Part 1: The ICER 2020-2023 Value Assessment Framework for Constructing Imaginary WorldsPaul C LangleyInnovations in Pharmacy|May 21, 2021
More Unnecessary Imaginary Worlds - Part 2: The ICER Evidence Report on Modeling Oral Semaglutide for Type 2 DiabetesPaul C LangleyInnovations in Pharmacy|May 19, 2021
Let a Thousand Models Bloom: ICER Analytics Opens the Floodgates to Cloud PseudosciencePaul C LangleyInnovations in Pharmacy|August 4, 2021
Peter Rabbit is a Badger in Disguise: Deconstructing the Belief System of the Institute for Clinical and Economic Review in Health Technology AssessmentPaul C LangleyInnovations in Pharmacy|August 29, 2022
A Critical Examination of Simulation Pricing and Access Recommendations for Atopic DermatitisPaul C LangleyInnovations in Pharmacy|May 23, 2022
Supping with the Devil: Belief and the Imaginary World of Multiple Myeloma Therapies Invented by the Institute for Clinical and Economic ReviewPaul C LangleyInnovations in Pharmacy|November 30, 2023
Post-Menopausal Quality of Life Claims: Overlooking the Requirements of Normal Science and Fundamental Measurement in ICER'S Cost-Effectiveness Assessment of Fezolinetant for Moderate to Severe Vasomotor SymptomsPaul C LangleyPageof 7